COVID-19 therapeutics I: Studies on the inhalation use of MAS receptor agonists in acute lung injury caused by COVID-19 (STAMINA) - synthesis process
- Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
- Total publications:0 publications
Grant number: 16LW0014
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$430,205.75Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)Principal Investigator
N/A
Research Location
GermanyLead Research Institution
ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbHResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Therapeutics logistics and supply chains and distribution strategies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable